39,174 results on '"ISONIAZID"'
Search Results
2. Tuberculosis Clinical Trials Consortium Study 35
3. Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI (ASTERoiD)
4. Shortened Regimen for Drug-susceptible TB in Children (SMILE-TB)
5. Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals
6. Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care
7. Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB (BREACH-TB)
8. Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
9. Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis (RAD-TB)
10. An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM (Co-SAM)
11. Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
12. Test and treat model for tuberculosis preventive treatment among household contacts of pulmonary tuberculosis patients in selected districts of maharashtra: A mixed-methods study on care cascade, timeliness, and early implementation challenges
13. Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection (PREVENT TB)
14. Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India
15. Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients
16. Impact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)
17. Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
18. ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa (ThiPhiSA)
19. Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
20. Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy
21. Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)
22. Preventive Therapy for Tuberculosis in HIV Infected Persons
23. Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet
24. Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis
25. Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial
26. Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings (HARAPAN II)
27. PanACEA - STEP2C -01
28. Using Biomarkers to Predict TB Treatment Duration
29. Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV (DOLPHIN Moms)
30. Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients (1 to 3)
31. Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
32. Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) (METHOD)
33. One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
34. Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
35. Tuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected Individuals
36. 1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam
37. Novel Triple-dose Tuberculosis Retreatment Regimen (Tri-Do-Re)
38. Intestinal obstruction following antituberculosis therapy in a patient with pancreatic carcinoma and pulmonary tuberculosis: a case report.
39. Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis.
40. Twice-Daily Dolutegravir–Based Antiretroviral Therapy With 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis Prevention.
41. Fabrication and in vitro–in vivo evaluation of ligand appended isoniazid loaded nanoparticulate systems for the treatment of tuberculosis.
42. Isoniazid Hybrids As Potential Antitubercular Agents.
43. Adsorption Effects of Isoniazid Drug Over Carbon Nanotube (C56H16) and Ab‐Initio Molecular Dynamics Simulation (ADMP) – A Computational Quantum Chemical Approach.
44. Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures.
45. Experimental and theoretical structural investigation of an ionic Nd coordination polymer.
46. Synthesis, Spectral Analysis, DFT Calculations, in Vitro Screening, and Molecular Docking of New Metal Complexes with Quinoline and Isoniazid Schiff Base as Antimicrobial and Antioxidant Agents.
47. Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.
48. The Hidden Epidemic of Isoniazid-Resistant Tuberculosis in South Africa.
49. Incidence of loss to follow-up and its predictors among HIV-infected under-five children after initiation of antiretroviral therapy in West Amhara Comprehensive Specialized Referral Hospitals, Northwest Ethiopia: a multicenter retrospective follow-up study
50. Estimation of isoniazid by digital image colorimetry: an integration of green chemistry and smartphone technology.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.